Search

everythinglearnresearchcommunity

for

Search:↓

New gel formulas without ethanol and propylene glycol, containing a minoxidil-methyl-β-cyclodextrin complex, have been created for treating hair loss.

Cyclophosphamide severely damages the intestinal lining in rats.

Topical cyclosporin promotes hair growth.

Congenital Adrenal Hyperplasia is mainly caused by enzyme deficiencies, leading to varying symptoms like hormone imbalances and physical changes.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

These chemicals can be toxic, causing health issues like cancer, liver damage, and irritation.

A new combination of tadalafil and finasteride improves drug performance and stability.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

New hybrid compound found to effectively prevent hair loss.

Hederagenin shows promise for cancer and inflammation treatment but needs modifications to improve effectiveness.

Hydrocortisone 17-butyrate 21-propionate ointment caused reversible side effects like skin issues, weight gain, and organ changes in dogs.

MXD@CP could be a promising new topical treatment for hair loss.

Overexpression of COX-2 in mice skin causes abnormal skin and hair development.

Melatonin stops melanin production after tyrosinase action, with cyclic GMP mimicking this effect.

Oral cyclosporine A and prednisolone effectively improved alopecia universalis without side effects.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Cyclooxygenase-2 overexpression in mice skin causes hair loss like human androgenetic alopecia.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

New treatments for skin diseases in 1979 showed promising results with fewer side effects.

Physcion may help treat hair loss by blocking an enzyme linked to baldness.